Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study For Safety and Efficacy Evaluation Of The Combined Ablation Procedure For The Treatment Of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

NCT01103674 is registered in ClinicalTrials.gov with nContact Surgical Inc. as lead sponsor.

NCT NCT01103674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01103674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study For Safety and Efficacy Evaluation Of The Combined Ablation Procedure For The Treatment Of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Lead sponsor
nContact Surgical Inc.
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation